ALFA Finder| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 76.5 | 60.1 | 41.2 |
| Other income | 1.0 | 0.2 | 0.1 |
| Total income | 77.5 | 60.3 | 41.3 |
| Profit before exceptional items & tax | 8.3 | 5.3 | 3.4 |
| Exceptional items | -0.1 | 0.0 | -0.0 |
| Profit before tax | 8.2 | 5.3 | 3.4 |
| Net profit | 5.3 | 3.3 | 2.4 |
| Operating margin | 10.6% | 8.8% | 8.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +120.80% |
|---|---|
| Net profit, quarter on quarter | +60.60% |
| Revenue, year on year | +85.70% |
| Operating profit, year on year | +121.20% |
| Operating profit, quarter on quarter | +43.10% |
NSE results filing, NSE: SOTAC. Figures extracted from the filing.
Sotac Pharmaceuticals Ltd: key numbers
- Share price
- ₹129.35
- Market cap
- ₹142.9 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹6.29 Cr
- P/E (TTM)
- 22.7×Sector 43.7×
- Promoter holding
- 72.85%
- FII holding
- 16.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sotac Pharmaceuticals Ltd
All →Sotac Pharmaceuticals Price Movement Clarification
Sotac Pharmaceuticals clarified that recent share price movements are entirely market-driven. The company confirmed it has disclosed all material information in compliance with SEBI regulations.
Sotac Pharmaceuticals Annual General Meeting
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals Capital Structure Change
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.